191 related articles for article (PubMed ID: 33729545)
1. N-glycan fingerprint predicts alpha-fetoprotein negative hepatocellular carcinoma: A large-scale multicenter study.
Huang C; Fang M; Feng H; Liu L; Li Y; Xu X; Wang H; Wang Y; Tong L; Zhou L; Gao C
Int J Cancer; 2021 Aug; 149(3):717-727. PubMed ID: 33729545
[TBL] [Abstract][Full Text] [Related]
2. Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma.
Dong B; Zhang H; Duan Y; Yao S; Chen Y; Zhang C
J Transl Med; 2024 May; 22(1):455. PubMed ID: 38741163
[TBL] [Abstract][Full Text] [Related]
3. A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma.
Luo CL; Rong Y; Chen H; Zhang WW; Wu L; Wei D; Wei XQ; Mei LJ; Wang FB
Technol Cancer Res Treat; 2019 Jan; 18():1533033819846632. PubMed ID: 31106685
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
5. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
[TBL] [Abstract][Full Text] [Related]
6. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma.
Best J; Bilgi H; Heider D; Schotten C; Manka P; Bedreli S; Gorray M; Ertle J; van Grunsven LA; Dechêne A
Z Gastroenterol; 2016 Dec; 54(12):1296-1305. PubMed ID: 27936479
[No Abstract] [Full Text] [Related]
7. A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.
Zhou D; Liu X; Wang X; Yan F; Wang P; Yan H; Jiang Y; Yang Z
BMC Cancer; 2021 Mar; 21(1):246. PubMed ID: 33685417
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
[TBL] [Abstract][Full Text] [Related]
9. Anti-BIRC5 autoantibody serves as a valuable biomarker for diagnosing AFP-negative hepatocellular carcinoma.
Li Q; Liu H; Wang H; Xiong W; Dai L; Zhang X; Wang P; Ye H; Shi J; Fang Z; Wang K
PeerJ; 2024; 12():e17494. PubMed ID: 38832035
[TBL] [Abstract][Full Text] [Related]
10. Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation Sequencing.
Yu Z; Wang R; Chen F; Wang J; Huang X
Dig Dis Sci; 2018 Apr; 63(4):945-957. PubMed ID: 29442275
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation.
Nörthen A; Asendorf T; Walson PD; Oellerich M
Clin Biochem; 2018 Feb; 52():20-25. PubMed ID: 29054441
[TBL] [Abstract][Full Text] [Related]
12. N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma.
Fang M; Zhao YP; Zhou FG; Lu LG; Qi P; Wang H; Zhou K; Sun SH; Chen CY; Gao CF
Int J Cancer; 2010 Jul; 127(1):148-59. PubMed ID: 19904744
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
[TBL] [Abstract][Full Text] [Related]
14. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
Na K; Jeong SK; Lee MJ; Cho SY; Kim SA; Lee MJ; Song SY; Kim H; Kim KS; Lee HW; Paik YK
Int J Cancer; 2013 Jul; 133(2):408-15. PubMed ID: 23319432
[TBL] [Abstract][Full Text] [Related]
15. Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC.
Wang M; Sanda M; Comunale MA; Herrera H; Swindell C; Kono Y; Singal AG; Marrero J; Block T; Goldman R; Mehta A
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):795-803. PubMed ID: 28223431
[No Abstract] [Full Text] [Related]
16. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
17. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.
Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512
[TBL] [Abstract][Full Text] [Related]
18. Serum N-glycan fingerprint helps to discriminate intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Huang C; Xu X; Wang M; Xiao X; Cheng C; Ji J; Fang M; Gao C
Electrophoresis; 2021 Jun; 42(11):1187-1195. PubMed ID: 33570803
[TBL] [Abstract][Full Text] [Related]
19. The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma.
Wang M; Devarajan K; Singal AG; Marrero JA; Dai J; Feng Z; Rinaudo JA; Srivastava S; Evans A; Hann HW; Lai Y; Yang H; Block TM; Mehta A
Cancer Prev Res (Phila); 2016 Feb; 9(2):172-9. PubMed ID: 26712941
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Yao M; Zhao J; Lu F
Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]